Abstract
p73 is a p53 homolog that, in vitro, inhibits cell growth and induce apoptosis. In some tumors p73 is monoallelically expressed and this raised the possibility that this gene is subjected to imprinting. Silencing of p73 in acute leukemia and in Burkitt's lymphoma occurs in association with the aberrant methylation of the first exon of the gene. We have analysed the methylation pattern of the p73 promoter and of upstream and downstream sequences in neuroblastoma. Our results demonstrate that p73 expression in this tumor is not regulated by methylation. We concluded that it is unlikely that p73 is imprinted in neuroblastoma and that the methylation-dependent silencing of this gene, thus far, is a characteristic of hematologic malignancies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bartolomei MS, Webber AL, Brunkow ME and Tilghman SM. . 1993 Genes Dev. 7: 1663–1673.
Bartolomei MS and Tilghman SM. . 1997 Annu. Rev. Genet. 31: 493–525.
Baylin SB, Herman JC, Graff JR, Vertino PM and Issa JP. . 1998 Adv. Cancer Res. 72: 141–196.
Caron H, Peter M, van Sluis P, Speleman F, de Kraker J, Laureys G, Michon J, Brugieres L, Voute PA, Westerveld A, Slater R, Delattre O and Versteeg R. . 1995 Hum. Mol. Genet. 4: 535–539.
Chi SG, Chang SG, Lee SJ, Lee CH, Kim JL and Park JH. . 1999 Cancer Res. 59: 2791–2793.
Corn PG, Kuerblitz SJ, van Noesel MM, Esteller M, Compitello N, Baylin SB and Herman JG. . 1999 Cancer Res. 59: 3352–3356.
Ding Y, Inoue T, Kamiyama J, Tamura Y, Ohtani-Fujita N, Igata E and Sakai T. . 1999 DNA Res. 6: 347–351.
Herman JG, Graff JR, Myohanen S, Nelkin B and Baylin SB. . 1996 Proc. Natl. Acad. Sci. USA 93: 9821–9826.
Ichimiya S, Nimura Y, Kageyama H, Takada N, Sunahara M, Shishikura T, Nakamura Y, Sakiyama S, Seki N, Ohira M, Kaneko Y, McKeon F, Caput D and Nakagawara A. . 1999 Oncogene 18: 1061–1066.
Jones PA and Laird PW. . 1999 Nature Genet. 21: 163–167.
Kaelin WG. . 1999a J. Natl. Cancer Inst. 91: 594–598.
Kaelin WG. . 1999b Oncogene 18: 7701–7705.
Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F and Caput D. . 1997 Cell 90: 809–819.
Kawano S, Miller CW, Gombart AF, Bartram CR, Matsuo Y, Asou H, Sakashita A, Said J, Tatsumi E and Koeffler P. . 1999 Blood 94: 1113–1120.
Kovalev S, Marchenko N, Swendeman S, LaQuaglia M and Moll UM. . 1998 Cell Growth Differ. 9: 897–903.
Lo Cunsolo C, Casciano I, Banelli B, Tonini GP and Romani M. . 1998 Cytogenet. Cell Genet. 82: 199–201.
Mai M, Yokomizo A, Qian C, Yang P, Tindall DJ, Smith DI and Liu W. . 1998a Cancer. Res. 58: 2347–2349.
Mai M, Qian C, Yokomizo A, Tindall DJ, Bostwick D, Polychronakos C, Smith DI and Liu W. . 1998b Oncogene 17: 1739–1741.
Nomoto S, Haruki N, Kondo M, Konishi H, Takahashi T and Takahashi T. . 1998 Cancer Res. 58: 1380–1383.
Peters UR, Tschan MP, Kreuzer KA, Baskaynak G, Lass U, Tobler A, Fey MF and Schmidt. . 1999 Cancer Res. 59: 4233–4236.
Prestridge DS. . 1991 CABIOS 7: 203–206.
Reese MG, Harris NL and Eeckman FH. . 1996 In: Large scale sequencing specific neural networks for promoter and splice site recognition. Biocomputing: Proceedings of the 1996 Pacific Symposium. Lawrence Hunter and Terri E. Klein (ed.). World Singapore: Scientific Publishing Co.
Romani M, Scaruffi P, Casciano I, Mazzocco K, Lo Cunsolo C, Cavazzana A, Gambini C, Boni L, De Bernardi B and Tonini GP. . 1999a Int. J. Cancer 84: 365–369.
Romani M, Marchi JV, Banelli B and Casciano I. . 1999b Anal. Biochem. 271: 204–207.
Sadri R and Hornsby PJ. . 1996 Nucleic Acid Res. 24: 5058–5059.
Scaruffi P, Casciano I, Masiero L, Basso G, Romani M and Tonini GP. . 2000 Leukemia 14: 518–519.
Toyota M, Coty H, Ahuja N, Jair KW, Li Q, Ohe-Toyota M, Baylin S and Issa JP. . 1999 Cancer Res. 59: 2307–2312.
Zaika AI, Kovalev S, Marchenko ND and Moll UM. . 1999 Cancer Res. 59: 3257–3263.
Acknowledgements
B Banelli is a fellow of the Associazione Italiana per la Lotta al Neuroblastoma. This work was supported by grants from the Associazione Italiana per la Lotta al Neuroblastoma and from the Health Ministry to M Romani, and from the National Research Council (CNR) to I Casciano.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Banelli, B., Casciano, I. & Romani, M. Methylation-independent silencing of the p73 gene in neuroblastoma. Oncogene 19, 4553–4556 (2000). https://doi.org/10.1038/sj.onc.1203807
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203807
Keywords
This article is cited by
-
Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis
Cell Death & Disease (2015)
-
Frequency variations in the methylated pattern of p73/p21 genes and chromosomal aberrations correlating with different grades of glioma among south Indian population
Medical Oncology (2011)
-
Meth-DOP-PCR: an assay for the methylation profiling of trace amounts of DNA extracted from bodily fluids
Laboratory Investigation (2006)
-
Epigenetics of cervical cancer. An overview and therapeutic perspectives
Molecular Cancer (2005)
-
Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors
Oncogene (2005)